We are live on ! Find out more
ACM

Argyle Capital Management Portfolio holdings

AUM $347M
1-Year Est. Return 44.33%
This Fund
S&P 500
This Quarter Est. Return
+4.09%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$182M
AUM Growth
+$7.71M
Cap. Flow
+$1.52M
Cap. Flow %
0.83%
Top 10 Hldgs %
24.06%
Holding
110
New
2
Increased
12
Reduced
34
Closed
1

Top Buys

Rank Stock Value
1
RIG icon
Transocean
RIG
+$753K
2
HPQ icon
HP
HPQ
+$389K
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$211K
4
MOLX
MOLEX INC
MOLX
+$209K
5
DLX icon
Deluxe
DLX
+$201K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$174K
2
AMGN icon
Amgen
AMGN
+$114K
3
CVX icon
Chevron
CVX
+$65.8K
4
HSY icon
Hershey
HSY
+$46.6K
5
SE
Spectra Energy Corp Wi
SE
+$41.5K

Sector Composition

Rank Sector Weight
1 Healthcare 23.76%
2 Technology 14.09%
3 Industrials 11.73%
4 Energy 11.58%
5 Consumer Staples 8.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIGI icon
101
Selective Insurance
SIGI
$5.65B
$245K 0.13%
10,002
TXN icon
102
Texas Instruments
TXN
$252B
$242K 0.13%
6,000
TFC icon
103
Truist Financial
TFC
$63.3B
$236K 0.13%
7,000
CL icon
104
Colgate-Palmolive
CL
$73.1B
$233K 0.13%
3,932
OSUR icon
105
OraSure Technologies
OSUR
$279M
$212K 0.12%
35,275
DLX icon
106
Deluxe
DLX
$1.18B
$208K 0.11%
+5,000
New +$201K
MUA icon
107
BlackRock MuniAssets Fund
MUA
$509M
$174K 0.1%
14,600
TLAB
108
DELISTED
TELLABS INC
TLAB
$34K 0.02%
14,800
EK
109
DELISTED
EASTMAN KODAK CO
EK
-13,900
Closed -$2K
GNBT
110
DELISTED
GENEREX BIOTECHNOLOGY CORP
GNBT
$0 ﹤0.01%
10,000

Similar funds

Argyle Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Argyle Capital Management held 110 positions worth $182M, up 4.4% from $174M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Trading was light in Q3 2013: portfolio turnover was 2.7%. Argyle Capital Management opened 2 new positions and exited 1, leaving the 110-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Argyle Capital Management's largest Q3 2013 buy was MOLEX INC: 6,500 shares worth $250K.
  • Argyle Capital Management added most to Transocean in Q3 2013, an estimated $753K increase.
  • Argyle Capital Management's biggest Q3 2013 reduction was 3M, cutting an estimated $174K.
  • Argyle Capital Management fully exited EASTMAN KODAK CO in Q3 2013, selling an estimated $2K.
  • Argyle Capital Management's ten largest holdings make up 24% of its $182M portfolio in Q3 2013.
  • Argyle Capital Management opened 2 new positions and closed 1 in Q3 2013.
  • Argyle Capital Management's portfolio value rose 4.4% quarter-over-quarter to $182M.

Based on Argyle Capital Management's 13F filing for Q3 2013, filed 31 Oct 2013.